Champions Oncology (CSBR) Q1 Fiscal 2027 Earnings Call: Revenue Up 9%, Services Margin Reaches 51%
Source Tradingkey
Key Takeaways
- First-quarter fiscal 2027 revenue increased approximately 9% year over year to $15.2 million from $14.0 million.
- Adjusted EBITDA rose to $671,000 from $59,000, marking the fifth consecutive quarter of positive adjusted EBITDA.
- GAAP net loss was approximately $426,000, including $1.1 million of noncash expense, compared with a prior-year loss of $527,000.
- Translational oncology services generated $14.3 million in revenue. The segment’s margin improved to 51% from 43%, supported by lower third-party radiolabeling costs and operating leverage.
- Data licensing revenue reached $893,000, exceeding the total generated in all of fiscal 2026. Management attributed the increase to a broader customer base.
- Champions Oncology ended the quarter with approximately $4.4 million in cash and no debt after using about $500,000 of cash, primarily due to working-capital movements.
Key Financial Data
| Metric | Q1 Fiscal 2027 | Prior-Year Quarter | Change or Context |
|---|---|---|---|
| Revenue | $15.2 million | $14.0 million | Up approximately 9% |
| Translational oncology services revenue | $14.3 million | — | Main revenue contributor |
| Data licensing revenue | $893,000 | — | More than all of fiscal 2026 |
| Oncology services margin | 51% | 43% | Improved by 8 percentage points |
| Adjusted EBITDA | $671,000 | $59,000 | Fifth consecutive positive quarter |
| GAAP net loss | $426,000 | $527,000 | Included $1.1 million of noncash expense |
| Cost of oncology revenue | $7.5 million | $8.0 million | Down approximately $500,000 |
| R&D expense | $1.9 million | $2.1 million | Lower core-services spending, with resources redirected to Corellia and data initiatives |
| Sales and marketing expense | $3.0 million | $1.8 million | Reflected expansion of the commercial organization |
| G&A expense | Approximately $2.1 million | Approximately $2.1 million | Essentially flat |
| Quarter-end cash | Approximately $4.4 million | — | No debt |
Business and Operating Performance
Disclaimer: For information purposes only. Past performance is not indicative of future results.
Recommended Articles
On Friday, September 11 (ET), the U.S. Bureau of Labor Statistics will release the Consumer Price Index (CPI) for August, the final major inflation report before the Federal Reserve's Sep
Brent holds above $100 as tanker attacks tighten supply — but four forces are capping the rallyBrent crude is holding above $100 a barrel for a second session, its first close above the level since late July, as tanker attacks near the Strait of Hormuz squeeze an already tight physical market. Yet the rally has been gradual: 8.3 mb/d of Gulf output is still shut in, diesel is at a record, and forecasts now range from $74 to $100.
Brent crude is holding above $100 a barrel for a second session, its first close above the level since late July, as tanker attacks near the Strait of Hormuz squeeze an already tight physical market. Yet the rally has been gradual: 8.3 mb/d of Gulf output is still shut in, diesel is at a record, and forecasts now range from $74 to $100.
Over 140,000 traders liquidated in crypto market as BTC drops for fourth straight day to test $78,000 level; altcoins crash.On September 10, the cryptocurrency market experienced a new ro
The U.S. Bureau of Labor Statistics will release the August Producer Price Index (PPI) at 8:30 a.m. ET on September 10. Against the backdrop of U.S. August non-farm payrolls significantly
On September 9, Brent crude futures broke above $100 per barrel intraday, crossing this threshold for the first time since July 24. As the military conflict between the US and Iran contin
